domingo, 7 de enero de 2018

NORD, FDA & Pfizer will be there- get involved now


Time is running out to get involved at the World Orphan Drug Congress USA!

This is your best opportunity for 2018 to showcase your solutions and network with  1000+ attendees from big pharma, biotechs, payers, patient groups, academics and government bodies


Companies already confirmed to attend include:

  • EURORDIS 
  • NORD
  • Spark Therapeutics
  • Sangamo Therapeutics
  • Editas Medicine
  • CRISPR Therapeutics 
  • FDA
  • NCATS/NIH
  • CADTH
  • Abeona Therapeutics
  • Orchard Therapeutics
  • McKesson
  • Medicaid Health Plans of America
  • Pfizer Rare Disease
  • Belgium Ministry of Public Health and Social Security
  • Cystic Fibrosis Foundation
  • rareLife solutions
  • Ablynx
  • Premier Research
  • Horizon Pharma
  • Japan Agency for Medical Research and Development
  • Invitae
  • bluebird bio
  • Roche
  • Alexion Pharmaceuticals
  • Parexel 
  • Jazz Pharmaceuticals
  • Canadian Organization For Rare Disorders
  • Intellia Therapeutics Inc.
  • Johnson & Johnson
  • Amgen Inc
  • Atlantic Research Group 
  • Cello Health
  • PPD
  • Kids v Cancer
  • Muscular Dystrophy Association
There are limited opportunities remaining. Contact Andre now at +1 646 619 1797 or andre.singer@terrapinn.comto showcase your solutions to your target audience this April. 

Regards, 

André Singer
General Manager 
World Orphan Drug Congress USA 2018
T: +1 646 619 1797

No hay comentarios: